Stay updated on Durvalumab and Tremelimumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Durvalumab and Tremelimumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer now shows revision v3.6.3, replacing v3.6.2. This reflects a minor update to the record history page interface.
    Difference
    0.1%
    Check dated 2026-07-03T22:08:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page’s revision notice updated from v3.6.0 to v3.6.2. This reflects a newer version of the site's interface/backend for the Record History view.
    Difference
    0.1%
    Check dated 2026-06-26T23:44:23.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Added a new revision entry v3.6.0 with a recruitment status note 'No longer looking for participants.' The previous revision entry v3.5.5 was removed.
    Difference
    0.2%
    Check dated 2026-06-12T13:35:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5. This indicates a new release of the page rendering rather than any change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-06-05T08:36:53.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    A new history entry was added on 2026-05-12 (Version 53) with Revision: v3.5.4. It includes a Study Status update in the Study Record Versions.
    Difference
    0.3%
    Check dated 2026-05-15T04:17:41.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.2 to v3.5.3, indicating a new version of the page's revision history. This reflects an update to the page's metadata without altering the underlying study data or functionality.
    Difference
    0.1%
    Check dated 2026-04-30T17:55:24.000Z thumbnail image

Stay in the know with updates to Durvalumab and Tremelimumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Durvalumab and Tremelimumab in NSCLC Clinical Trial page.